PharmAthene (PIP)
Add to Watchlists Create an Alert
1.60
-0.02 -1.23%
AMEX
May 24, 8:00PM
BATS Real time
Currency in USD
PharmAthene Return on Equity:
-36.50% for Dec. 31, 2012PharmAthene Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -36.50% |
| Sept. 30, 2012 | -20.65% |
| June 30, 2012 | -18.95% |
| March 31, 2012 | -31.87% |
| Dec. 31, 2011 | -28.13% |
| Sept. 30, 2011 | -257.5% |
| June 30, 2011 | -776.5% |
| March 31, 2011 | |
| Dec. 31, 2010 | |
| Sept. 30, 2010 | |
| June 30, 2010 | -3289% |
| March 31, 2010 | -545.9% |
| Dec. 31, 2009 | -290.8% |
| Sept. 30, 2009 | -250.4% |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
PIP Return on Equity Benchmarks
| Companies | |
|---|---|
| Emergent BioSolutions | 5.23% |
| BioTime | -134.7% |
| Savient Pharmaceuticals |
PIP Return on Equity Rankings
| Overall |
46th percentile 4059 of 7600 |
| Sector |
51st percentile 318 of 653 in Healthcare |
| Industry |
74th percentile 60 of 238 in Biotechnology |
PIP Return on Equity Range, Past 5 Years
| Minimum | -3289% | Jun 2010 |
| Maximum | -18.95% | Jun 2012 |
| Average | -411.1% |
